SG biotech firm Nuevocor raises $24m in oversubscribed Series A round 2021-06-18T09:48:18-04:00June 18th, 2021| share this article! Nuevocor, a Singapore-based preclinical-stage biotech startup, has announced raising $24m in an oversubscribed Series A funding round. Read More share this article! Related Posts India’s Vodafone Idea in talks to avail $1.8b loans over two years May 2nd, 2024 AI-SaaS company AiDash closes Series C round at $58.5m led by Lightsmith Group May 2nd, 2024 In Asia, US dollar’s growing strength fuels concern over currency stability May 2nd, 2024 Morgan Stanley, India Life Sciences Fund inject $120m into India’s Maiva Pharma May 2nd, 2024
